Epitope Imprinted Nanoparticles as Customized Synthetic Antibodies for Biorecognition in Theranostics
Open Access
- 5 December 2025
- journal article
- Published by Springer Nature in Regenerative Engineering and Translational Medicine
- Vol. 12 (3) , 827-848
Abstract
As medicine advances towards an era of personalized and targeted therapies, the need for precise and reliable molecular recognition elements becomes increasingly critical. These elements are essential for directing therapeutic agents to specific cells or tissues, thereby maximizing efficacy while minimizing off-target effects. Among the emerging technologies, epitope-imprinted nanoparticles (EINPs) have demonstrated exceptional potential as “synthetic antibodies” for the recognition of biomarkers. These nanoparticles are designed to mimic the binding capabilities of natural antibodies but with enhanced stability, specificity, and ease of production. Unlike traditional antibodies, which can be costly, labile, and prone to significant side effects, EINPs offer a cost-effective, robust, and customizable platform for targeted sensing and therapeutic applications. This Perspective Review explores the design, synthesis, and application of epitope-imprinted nanoparticles, highlighting their advantages and potential to revolutionize the landscape of abiotic molecular recognition in disease detection and targeted therapies. Finally, we present perspectives on foreseeable breakthroughs and advances, offering insights into how molecular imprinting techniques can be expanded to new biomedical fields, such as tissue engineering. Lay Summary: Personalized medicine requires precise tools to identify and target diseased cells while avoiding off target effects. Epitope-imprinted nanoparticles (EINPs) are emerging as synthetic alternatives to antibodies, designed to recognize disease markers with high stability, low cost, and fewer limitations than natural antibodies. By mimicking biological recognition, EINPs show promise in applications such as disease detection, drug delivery, and tissue engineering. This perspective review focus on how these nanoparticles are created and applied, and highlights their potential to transform regenerative medicine and targeted therapies through more reliable, customizable molecular recognition systems.Keywords
Funding Information
- HORIZON EUROPE European Research Council (101171765)
- Fundação para a Ciência e a Tecnologia (10.54499/2022.05526.PTDC, 10.54499/2020.03410.CEECIND/CP1600/CT0013, 10.54499/UIDB/50026/2020, 10.54499/UIDP/50026/2020, 10.54499/LA/P/0050/2020, PINFRA/22190/2016)
- Comissão de Coordenação e Desenvolvimento Regional do Norte (Norte-01-0145-FEDER-022190)
This publication has 127 references indexed in Scilit:
- Double Imprinted Nanoparticles for Sequential Membrane‐to‐Nuclear Drug DeliveryAdvanced Science, 2024
- Guiding Stem Cell Tenogenesis by Modulation of Growth Factor Signaling and Cell‐Scale Biophysical Cues in Bioengineered ConstructsAdvanced Functional Materials, 2024
- Plastic Antibodies Mimicking the ACE2 Receptor for Selective Binding of SARS‐CoV‐2 SpikeAdvanced Materials Interfaces, 2022
- Controllable Engineering and Functionalizing of Nanoparticles for Targeting Specific Proteins towards Biomedical ApplicationsAdvanced Science, 2021
- Epitope‐Imprinted Nanoparticles as Transforming Growth Factor‐β3 Sequestering Ligands to Modulate Stem Cell FateAdvanced Functional Materials, 2020
- Biomaterials for Sequestration of Growth Factors and Modulation of Cell BehaviorAdvanced Functional Materials, 2020
- Molecularly Imprinted Nanoparticles for Biomedical ApplicationsAdvanced Materials, 2019
- Cell and Tissue Imaging with Molecularly Imprinted Polymers as Plastic Antibody MimicsAdvanced Healthcare Materials, 2015
- Photolithographic Boronate Affinity Molecular Imprinting: A General and Facile Approach for Glycoprotein ImprintingAngewandte Chemie International Edition, 2013
- Selective Protein Capture by Epitope ImprintingAngewandte Chemie International Edition, 2006